Evidence map›Paper›PMID 42388751›Full record

ArticleFrontiers in public health2026

Integrating lipid-related composite indices and explainable machine learning for coronary heart disease risk assessment.

Yanchao Liu, Xuli Chen, Yuelin Hu, Kaiyu Shi, Wenwen Xiao, Chenchen Ang

Abstract read
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yanchao LiuDepartment of Electrocardiology, The Second Affiliated Hospital of Wannan Medical University, Wuhu, China.
Xuli ChenDepartment of Electrocardiology, The Second Affiliated Hospital of Wannan Medical University, Wuhu, China.
Yuelin HuDepartment of Electrocardiology, The Second Affiliated Hospital of Wannan Medical University, Wuhu, China.
Kaiyu ShiAnhui College of Traditional Chinese Medicine, Wuhu, China.
Wenwen XiaoEastern Theater Command Centers for Disease Control and Prevention, Nanjing, China.
Chenchen AngJinghu District Hospital of Wuhu City, Wuhu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Composite indices integrating inflammation and lipid metabolism have emerged as promising markers for coronary heart disease (CHD), yet their comparative performance and discriminative ability for identifying CHD status remain incompletely understood. Methods: In this hospital-based study, 270 patients were enrolled, including 99 with CHD and 171 without CHD. Exposures included C-reactive protein (CRP) and composite indices (TG/HDL, LDL/HDL, AIP, CRP/HDL, and CRP/TG). Logistic regression, restricted cubic spline (RCS), and subgroup analyses were used to evaluate associations with CHD. Machine learning models were developed using significant predictors, and model performance was assessed by AUC, calibration, and decision curve analysis. SHapley Additive exPlanations (SHAP) were applied to interpret model outputs. Results: After multivariable adjustment, TG/HDL (OR = 2.74, 95% CI: 1.10-7.10), LDL/HDL (OR = 3.01, 95% CI: 1.21-7.81), and AIP (OR = 6.59, 95% CI: 1.61-28.51) were associated with increased odds of CHD, whereas CRP and CRP-based indices were not. RCS analyses indicated no significant nonlinearity, suggesting monotonic associations. Subgroup analyses showed generally consistent results across key strata. In classification modeling, ensemble tree-based methods performed best, with random forest and XGBoost achieving the highest discrimination ability (AUC = 0.748). SHAP analysis identified age and lipid-related composite indices as the primary contributors to CHD classification. Conclusion: Lipid-related composite indices, particularly TG/HDL, LDL/HDL, and AIP, are robust markers associated with CHD status and can be effectively integrated into machine learning models for individualized CHD classification.

Indexed as

Coronary DiseaseLipidsMachine LearningAgedBiomarkersBoosting Machine Learning AlgorithmsC-Reactive ProteinFemaleHumansMaleMiddle AgedPredictive Learning ModelsRandom ForestRisk AssessmentBiomarkersC-Reactive ProteinLipidsCHDlipidmachine learningrisk assessmentSHAP

Identifiers

PMID42388751
PMCPMC13319073

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.